Professional Summary

Professional Overview

Mark Schneyer is a seasoned finance and business executive with over 25 years of experience in the pharmaceutical and healthcare industries. As the Chief Financial Officer and Senior Vice President of Business Development at Acadia Pharmaceuticals Inc., he brings a unique blend of financial acumen and strategic leadership to his role.

Experience Summary

Current Role

In his current position as Chief Financial Officer, Mark is responsible for overseeing all financial operations, reporting, and strategic decision-making at Acadia Pharmaceuticals. He also serves as the Senior Vice President of Business Development, where he leads the company's merger and acquisition efforts, strategic partnerships, and other business development initiatives. Under his financial leadership, Acadia has achieved significant growth and improved its financial performance.

Career Progression

Prior to joining Acadia, Mark held various leadership roles at Pfizer, including Vice President of Worldwide Business Development and Vice President of Business and Corporate Development for the Upjohn division. In these positions, he was instrumental in securing strategic partnerships, divestitures, and acquisitions that contributed to Pfizer's overall growth and expansion. Earlier in his career, Mark spent over a decade as a Director at Lazard, where he advised clients on mergers, acquisitions, and other complex financial transactions.

Academic Background

Mark holds a Bachelor's degree in Finance from a leading university, where he graduated with honors. He has also completed executive education programs at renowned business schools, further enhancing his expertise in strategic financial management and business development.

Areas of Expertise

Mark's areas of expertise include financial management, strategic planning, mergers and acquisitions, business development, and commercial operations within the pharmaceutical and healthcare industries. He is adept at identifying and capitalizing on growth opportunities, managing financial risks, and aligning business strategies with financial objectives.

Professional Impact

Throughout his career, Mark has played a pivotal role in driving the success of the organizations he has served. At Acadia Pharmaceuticals, he has been instrumental in securing strategic partnerships, expanding the company's product pipeline, and improving its financial performance. His ability to navigate complex financial and business challenges, coupled with his strong leadership skills, has made him a valuable asset to the companies he has worked for.

Conclusion

With his extensive experience, deep industry knowledge, and proven track record of success, Mark Schneyer is well-positioned to continue making a significant impact as the Chief Financial Officer and Senior Vice President of Business Development at Acadia Pharmaceuticals. His versatile skillset and strategic mindset make him a valuable addition to the company's executive team.